Huh Hoyoung
Insider CIK 1401267 · CTMX Director · ANTB Chairman, Scientific Adv. Bd., Director, 10% owner · AKTX Director, 10% owner · EIDX Director · PLRX Director · PKBO Director, 10% owner · GERN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTX Akari Therapeutics Plc | A Award | 2026-10-05 | 2026-10-16 | 6,160 | $7.90 | $48.7K | 140,805 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-08-18 | 2026-10-16 | 17,249 | $7.90 | $136.2K | 134,645 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-06-11 | 2026-06-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 618,658 | — | $0 | 618,658 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 618,658 | $0.40 | $247.5K | 618,658 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 3,093,293 | $0.40 | $1.24M | 3,093,293 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 3,093,293 | — | $0 | 3,093,293 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-06-05 | 2025-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 892,857 | $1.12 | $1000.0K | 892,857 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 892,857 | $1.12 | $1000.0K | 892,857 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-03-06 | 2025-03-10 | 892,857 | $1.12 | $1000.0K | 4,695,854 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer deriv | 2024-11-14 | 2024-11-18 | 1,200,000 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | C Conversion deriv | 2024-11-14 | 2024-11-18 | 176,292 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer deriv | 2024-11-14 | 2024-11-18 | 0 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | C Conversion | 2024-11-14 | 2024-11-18 | 4,574,661 | — | $0 | 4,574,661 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 8,382,742 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 372,940 | — | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | D To issuer | 2024-11-14 | 2024-11-18 | 4,574,661 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-06-13 | 2024-06-17 | 26,764 | — | $0 | 26,764 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-21 | 2023-09-25 | 45,000 | — | $0 | 8,382,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-20 | 2023-09-21 | 30,000 | — | $0 | 8,337,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-19 | 2023-09-21 | 50,000 | — | $0 | 8,307,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-15 | 2023-09-19 | 25,000 | — | $0 | 8,257,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-14 | 2023-09-15 | 20,000 | — | $0 | 8,232,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-13 | 2023-09-15 | 30,000 | — | $0 | 8,212,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-12 | 2023-09-13 | 17,000 | — | $0 | 8,182,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-09-11 | 2023-09-13 | 30,000 | — | $0 | 8,165,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-31 | 2023-09-01 | 13,000 | $0.27 | $3.5K | 8,228,992 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-31 | 2023-09-12 | 0 | — | $0 | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-01 | 3,750 | $0.25 | $938 | 8,148,492 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-01 | 1,000 | $0.25 | $250 | 8,142,242 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-01 | 2,500 | $0.26 | $650 | 8,144,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-01 | 11,400 | $0.27 | $3.1K | 8,159,892 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-01 | 56,100 | $0.26 | $14.6K | 8,215,992 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-12 | 0 | — | $0 | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-12 | 0 | — | $0 | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-12 | 0 | — | $0 | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-12 | 0 | — | $0 | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-30 | 2023-09-12 | 0 | — | $0 | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-29 | 2023-09-01 | 5,500 | $0.25 | $1.4K | 8,141,242 | SEC↗ |
| PKBO Peak Bio, Inc. | P Buy | 2023-08-29 | 2023-09-12 | 0 | — | $0 | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | X Exercise deriv | 2023-08-14 | 2023-08-15 | 583,333 | — | $0 | 176,292 | SEC↗ |
| PKBO Peak Bio, Inc. | X Exercise | 2023-08-14 | 2023-08-15 | 583,333 | $0.60 | $350.0K | 8,135,742 | SEC↗ |
| PKBO Peak Bio, Inc. | X Exercise deriv | 2023-07-20 | 2023-07-21 | 458,333 | — | $0 | 759,625 | SEC↗ |
| PKBO Peak Bio, Inc. | X Exercise | 2023-07-20 | 2023-07-21 | 458,333 | $0.60 | $275.0K | 7,552,409 | SEC↗ |
| PKBO Peak Bio, Inc. | X Exercise deriv | 2023-06-23 | 2023-06-27 | 666,667 | — | $0 | 1,217,958 | SEC↗ |
| PKBO Peak Bio, Inc. | X Exercise | 2023-06-23 | 2023-06-27 | 666,667 | $0.60 | $400.0K | 7,094,076 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-06-07 | 2023-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PKBO Peak Bio, Inc. | A Award deriv | 2023-04-28 | 2023-05-02 | 0 | $1130775.00 | $0 | 0 | SEC↗ |
| PKBO Peak Bio, Inc. | A Award deriv | 2023-04-28 | 2023-05-02 | 1,884,625 | — | $0 | 1,884,625 | SEC↗ |
| PKBO Peak Bio, Inc. | J Other | 2022-11-01 | 2022-11-03 | 6,442,438 | — | $0 | 6,422,438 | SEC↗ |
| PKBO Peak Bio, Inc. | J Other | 2022-11-01 | 2022-11-03 | 372,562 | — | $0 | 372,652 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-06-16 | 2022-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-06-29 | 2021-06-30 | 13,286 | — | $0 | 13,286 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 1,000,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 139,860 | — | $0 | 239,619 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award deriv | 2018-06-22 | 2018-06-22 | 83,720 | — | $0 | 83,750 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 14,000 | — | $0 | 14,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2018-05-15 | 2018-05-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GERN GERON CORP | A Award | 2017-12-29 | 2018-01-02 | 10,764 | — | $0 | 154,301 | SEC↗ |
| GERN GERON CORP | A Award | 2017-09-29 | 2017-10-02 | 8,888 | — | $0 | 143,537 | SEC↗ |
| GERN GERON CORP | A Award | 2017-06-30 | 2017-06-30 | 6,995 | — | $0 | 134,649 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 14,000 | — | $0 | 14,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2017-05-09 | 2017-05-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GERN GERON CORP | A Award | 2017-03-31 | 2017-03-31 | 8,535 | — | $0 | 127,654 | SEC↗ |
| ANTB AntriaBio, Inc. | A Award deriv | 2016-10-31 | 2017-01-18 | 4,000,000 | — | $0 | 4,000,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2016-06-10 | 2016-06-14 | 28,000 | — | $0 | 28,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2016-05-17 | 2016-05-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ANTB AntriaBio, Inc. | J Other deriv | 2016-03-31 | 2014-04-09 | 234,700 | — | $0 | 234,700 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2015-05-18 | 2015-05-19 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | D To issuer | 2014-06-30 | 2014-07-02 | 10,000 | — | $0 | 119,119 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2014-05-20 | 2014-05-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | A Award | 2014-03-31 | 2014-04-02 | 9,270 | — | $0 | 129,119 | SEC↗ |
| ANTB AntriaBio, Inc. | A Award | 2014-03-31 | 2014-04-09 | 1,057,693 | $275000.00 | $290.87B | 5,057,693 | SEC↗ |
| GERN GERON CORP | A Award | 2013-12-31 | 2014-01-03 | 4,088 | — | $0 | 119,849 | SEC↗ |
| GERN GERON CORP | A Award | 2013-09-30 | 2013-10-01 | 5,784 | — | $0 | 115,761 | SEC↗ |
| GERN GERON CORP | D To issuer | 2013-07-09 | 2013-07-10 | 45,000 | — | $0 | 109,977 | SEC↗ |
| GERN GERON CORP | A Award | 2013-06-28 | 2013-07-02 | 12,450 | — | $0 | 154,977 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2013-05-22 | 2013-05-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | D To issuer | 2012-12-31 | 2013-01-03 | 10,000 | — | $0 | 142,527 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2012-05-17 | 2012-05-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | A Award | 2012-05-17 | 2012-05-18 | 21,277 | — | $0 | 152,527 | SEC↗ |
| ANTB AntriaBio, Inc. | A Award deriv | 2012-04-30 | 2014-05-02 | 350,000 | — | $0 | 2,850,000 | SEC↗ |